Fulvestrant (Faslodex®) demonstrates clinical benefit in heavily pretreated postmenopausal women with advanced breast cancer: a single-center experience. - Franco,S.; Perez,A.; Tan-Chiu,E.; Frankel,C.; Vogel,C. (Br Cancer Res Treat, 2003)